Trumenba
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Background: In February 2015, two unlinked culture-confirmed cases of Neisseria meningitidis serogroup B (MenB) disease occurred…
In response to a university-based serogroup B meningococcal disease outbreak, the serogroup B meningococcal vaccine Trumenba was…
ABSTRACT Neisseria meningitidis is a major cause of bacterial meningitis and sepsis worldwide. Capsular polysaccharide vaccines…
Trumenba (bivalent rLP2086) is a vaccine licensed for the prevention of meningococcal meningitis disease caused by Neisseria…
Summary Immunisation against meningococcal meningitis has a long history, which has passed through several phases: the studies by…